Similar articles

• Allogeneic hematopoietic stem cell transplantation for metastatic breast cancer.

  Bishop MR. Bishop MR. Haematologica. 2004 May;89(5):599-605. Haematologica. 2004. PMID: 15136224 Review.
• Tumor cell purging by ex vivo expansion of hemopoietic stem cells from breast cancer patients combined with targeting ErbB receptors.

  Leone F, Cavalloni G, Gunetti M, Pignochino Y, Piacibello W, Aglietta M. Leone F, et al. Biol Blood Marrow Transplant. 2006 Jan;12(1):68-74. doi: 10.1016/j.bbmt.2005.06.003. Biol Blood Marrow Transplant. 2006. PMID: 16399570
• A comparison between low intensity and reduced intensity conditioning in allogeneic hematopoietic stem cell transplantation for solid tumors.

  Conrad R, Remberger M, Cederlund K, Ringdén O, Barkholt L. Conrad R, et al. Haematologica. 2008 Feb;93(2):265-72. doi: 10.3324/haematol.11672. Haematologica. 2008. PMID: 18245651 Clinical Trial.
• High-dose chemotherapy and autologous hematopoietic stem cell transplantation for metastatic breast cancer: a therapy whose time has passed.

  Vogl DT, Stadtmauer EA. Vogl DT, et al. Bone Marrow Transplant. 2006 Jun;37(11):985-7. doi: 10.1038/sj.bmt.1705366. Bone Marrow Transplant. 2006. PMID: 16708060 Review. No abstract available.
• Graft--versus--breast cancer effect by allogeneic hematopoietic stem-cell transplantation: a possible new frontier.

  Ueno NT, Shpall EJ, Champlin RE, Jones RB. Ueno NT, et al. J Clin Oncol. 2004 Oct 1;22(19):3846-7. doi: 10.1200/JCO.2004.06.922. Epub 2004 Aug 16. J Clin Oncol. 2004. PMID: 15314060 No abstract available.